Duration: (6:38) ?Subscribe5835 2025-02-13T19:09:09+00:00
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide
(6:38)
Dr. Silke Gillessen Invites You to Submit to ASCO #GU24
(42)
Dr. Todd Morgan on Why You Should Submit to ASCO #GU24
(33)
Dr. Silke Gillessen Invites You to Attend ASCO #GU24
(47)
ASCO GU24 special: Dr. Andrea Apolo shares AMBASSADOR results
(8:19)
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
(10:51)
ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 results
(5:)
ASCO GU24 special: Prof. Christophe Hennequin on GETUG-AFU 18 trial results
(3:38)
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results
(13:10)
ASCO VALVES
(9:1econd)
Episode 3: ASCO GU 2024 Commentary: Kidney Cancer - The View on GU | with Lalani \u0026 Wallis
(30:52)
The Kickoff! The View on GU | with Lalani \u0026 Wallis
(12:17)
Estudios ARASENS ASCO GU 2022
(23:20)
ASCO GU Research to Watch: Kidney Cancer
(3:18)
ASCO #GU24: Alok Tewari, MD, PhD | Dana-Farber Cancer Institute
(2:23)
ASCO #GU24 Celebrates 20 Years!
(4:15)
Have you watched our three-episode series on ASCO #GU24 yet?
(41)
What’s New in Prostate Cancer, RCC, and mUC at GU24
(25:10)
2022 ASCO GU Cancers Symposium Keynote | A Path Forward: Addressing Disparities in GU Cancers
(29:57)
Episode 1: ASCO GU 2024 Commentary: Prostate Cancer - The View on GU | with Lalani \u0026 Wallis
(31:14)
2020 ASCO-GU Prostate Cancer Update | Ask a Prostate Cancer Expert
(6:9)
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
(30:25)
ASCOGU24: Xiao Wei, MD on TPS244 | Dana-Farber Cancer Institute
(2:1econd)